BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36969150)

  • 1. Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.
    Ma Y; Zhang P; Bao Y; Luo H; Wang J; Huang L; Zheng M
    Front Immunol; 2023; 14():1093719. PubMed ID: 36969150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics.
    Wang Y; Zhang M; Xue Q; Zhou H; Chen J; Wang H; Zhang Y; Shi W
    Front Immunol; 2023; 14():1172307. PubMed ID: 37138889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection.
    Song Y; Wang J; Wang Y; Wu L; You Y; Song D; Chen L; Meng G; He X; Cui T; Wang X; Yin Q; Wang Z
    Clin Microbiol Infect; 2023 Jun; 29(6):796.e7-796.e13. PubMed ID: 36702399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
    Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
    Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive pericardial effusion due to chronic active Epstein-Barr virus infection successfully treated with PD-1 blockade: A case report.
    Pi Y; Wang J; Wang Z
    Medicine (Baltimore); 2022 Aug; 101(34):e30298. PubMed ID: 36042605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of adult-onset chronic active Epstein-Barr virus infection].
    Kawamoto K; Miyoshi H; Seto M; Kimura H; Ohshima K
    Rinsho Ketsueki; 2019; 60(8):944-952. PubMed ID: 31484894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.
    Watanabe Y; Sasahara Y; Satoh M; Looi CY; Katayama S; Suzuki T; Suzuki N; Ouchi M; Horino S; Moriya K; Nanjyo Y; Onuma M; Kitazawa H; Irie M; Niizuma H; Uchiyama T; Rikiishi T; Kumaki S; Minegishi M; Wada T; Yachie A; Tsuchiya S; Kure S
    Eur J Haematol; 2013 Sep; 91(3):242-248. PubMed ID: 23734904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed death 1 monoclonal antibody helped to treat mixed chimeric and reactivation of Epstein-Barr virus in a patient with adult-onset chronic active Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation: A case report.
    You Y; Wang J; Wang Z
    Medicine (Baltimore); 2022 Jan; 101(2):e28542. PubMed ID: 35029211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein-Barr virus infection.
    Ma H; Zhang L; Wei A; Yang J; Wang D; Zhang Q; Zhao Y; Chen S; Lian H; Zhang L; Zhou C; Qin M; Li Z; Wang T; Zhang R
    Orphanet J Rare Dis; 2021 Jun; 16(1):269. PubMed ID: 34112210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis.
    Xiao H; Hu B; Luo R; Hu H; Zhang J; Kuang W; Zhang R; Li L; Liu G
    Virol J; 2020 Oct; 17(1):166. PubMed ID: 33121509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated guidelines for chronic active Epstein-Barr virus disease.
    Kawada JI; Ito Y; Ohshima K; Yamada M; Kataoka S; Muramatsu H; Sawada A; Wada T; Imadome KI; Arai A; Iwatsuki K; Ohga S; Kimura H;
    Int J Hematol; 2023 Nov; 118(5):568-576. PubMed ID: 37728704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
    Sakamoto Y; Mariya Y; Kubo K
    Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploidentical hematopoietic stem cell transplantation for pediatric patients with chronic active Epstein-Barr virus infection: a retrospective analysis of a single center.
    Luo YH; Yang J; Wei A; Zhu GH; Wang B; Zhang R; Jia CG; Yan Y; Wang K; Li S; Zhou X; Qin MQ; Wang TY
    World J Pediatr; 2021 Dec; 17(6):626-636. PubMed ID: 34739695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic active Epstein-Barr virus infection involving gastrointestinal tract with hemophagocytic lymphohistiocytosis.
    Shen K; Shuai X; Li J; Liu J; Liu T; Niu T; Ma H
    Ann Hematol; 2023 Jan; 102(1):45-53. PubMed ID: 36534145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options.
    Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C
    BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.